openPR Logo
Press release

Irritable Bowel Syndrome Treatment Market to Reach $2,012 Million by 2026

03-25-2020 02:01 PM CET | Health & Medicine

Press release from: Allied Market Research

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market size was valued at $ 1,071 million in 2018, and is projected to reach $2,012 million by 2026, growing at a CAGR of 8.2% from 2019 to 2026.

Irritable bowel syndrome is a gastrointestinal tract (GT) illness with the symptoms such as alteration of bowel habits and severe abdominal pain. Usually, the digested food passes through the gastrointestinal tract (GT) and the movement of food is due to intestinal muscle contraction.

The irritable bowel syndrome hinders natural movements of that muscle; thus, food material cannot pass through the digestive tract and may result in abdominal pain, diarrhea, mucus in the stool, constipation, bloating & gas, and cramping. The Centers for Disease Control and Prevention (CDC) suggested that nearly 3 million people in the U.S. were reported being treated with irritable bowel syndrome in 2015. The irritable bowel syndrome can be treated by making changes by proper medication, making changes in daily diet, and reducing stress.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/6313

The major factors that boost the growth of the global irritable bowel syndrome treatment market are adoption of sedentary lifestyle, rise in level of stress, unhealthy diet, rise in geriatric population, surge in prevalence of gastrointestinal diseases and disorders such as alteration of bowel habit, & abdominal pain, increase in awareness programs for irritable bowel syndrome treatment, and launches of various developed pipeline drugs for the irritable bowel syndrome treatment during the forecast period.

Moreover, increase in prevalence of irritable bowel syndrome in female is expected to further drive the growth of the global irritable bowel treatment market. However, lack of specific treatment which treat all the symptoms of this disorder, and high competition among the key players related to pricing are expected to restrain the irritable bowel syndrome treatment market growth.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6313

Key Findings of the Study:
o Based on type, the IBS with diarrhea (IBS-D) segment held 47.76% share in the global market in 2018.
o Based on product, the rifaximin segment accounted for the largest irritable bowel syndrome treatment market share in 2018 and is expected to remain dominant throughout the forecast period.
o Based on end user, the drug stores & retail pharmacies segment held 54.01% share in the global market in 2018.
o Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.9% during the forecast period.

In 2018, North America accounted for the major share in the irritable bowel syndrome market size and is expected to continue this trend, owing to availability of well-developed infrastructure facilities, presence of majority of the key players, rise in gastrointestinal diseases, and huge availability of trained medical professionals. On the other hand, Asia-Pacific is estimated to register the fastest growth during the forecast period, owing to rise in disposable income, high population base, surge in the geriatric population, and increase in patient awareness toward irritable bowel syndrome treatment.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Irritable Bowel Syndrome Treatment Market to Reach $2,012 Million by 2026 here

News-ID: 1984030 • Views: 63

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Irritable

Irritable Bowel Syndrome Drugs and Companies Research
Summary Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months. IBS is classified into three main subtypes, according to the predominant bowel habit: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and mixed-presentation (IBS-M) IBS. The IBS treatment landscape remains largely underserved, and
Global Irritable Bowel Syndrome Industry 2018 - Actavis, Astellas Pharma, Nestle …
The Global Irritable Bowel Syndrome Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Irritable Bowel Syndrome industry. Firstly, Irritable Bowel Syndrome Market report provides a basic overview of the Irritable Bowel Syndrome industry including definitions, classifications, applications and Irritable Bowel Syndrome industry chain structure. Global Irritable Bowel Syndrome Market analysis is provided for the international market including development history, Irritable Bowel Syndrome
Irritable Bowel Syndrome Treatment Market Trends & Projection to 2022
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performed
Irritable Bowel Syndrome Treatment Market Forecasts, Trends and analysis 2023
A comprehensive analysis of the EMEA (Europe, Middle East and Africa) Irritable Bowel Syndrome Treatment Market is been done in this intelligence report. It includes the investigations done on the past progress, ongoing market scenarios, and future prospects. An accurate data of the products, strategies and market shares of leading companies in this particular market is mentioned. This report presents a 360-degree overview of the competitive scenario of the EMEA
Global Irritable Bowel Syndrome (IBS) Research Report 2017-2022 : Takeda, IM Hea …
Qyresearchreports include new market research report "Global Irritable Bowel Syndrome (IBS) Research Report 2017-2022" to its huge collection of research reports. A new report has been added to the expansive database of QYResearchReports.com. The report is based on the global Irritable Bowel Syndrome (IBS) market. The report is a comprehensive analysis of the key factors impacting the growth of the global Irritable Bowel Syndrome (IBS) market. This includes growth drivers and
Irritable Bowel Syndrome Treatment Market to Develop Rapidly by 2022
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performed